Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increase clinical data accuracy and promoting positive health economics.
Observe Medical invites investors, analysts, and other stakeholders to a presentation with trading update 25 March 2026, at 10:00 CET. The presentation will be streamed via webcast here.
Observe Medical is building a scalable Nordic medtech platform — combining a portfolio of proprietary products and innovation with partnerships that leverage our manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.
Oslo, 9 April 2026 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) has been informed that Glimt Invest AS, a close associate of Terje Bakken, Chairman of the Board and primary insider of the Company, has purchased 182,000 shares in the Company. Jørgen Mann, Chief Executive Officer of the Company, has purchased…
Read moreOslo, 9 April 2026 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) has today granted 250,000 share options to primary insider and CEO of the Company, Jørgen Mann. Each share option gives the right to subscribe for or purchase one share in the Company or to receive a cash payment of a…
Read moreOslo, February 27, 2026 - Observe Medical ("the Company" or "Observe Medical") today releases its results for the second half and the full year of 2025. Highlights · Revenue growth: UnoMeter™ portfolio revenues of NOK 7.5 million in the second half, representing an increase of 69% from the same period in 2024. For the full year…
Read more